Isabel Pavia/Getty Images
<p>The Food &; Drug Administration (FDA) has approved the United State&#8217;s first over-the-counter birth control pill. According to <a href="https://www.cnn.com/2023/07/13/health/fda-otc-birth-control-opill/index.html" target="_blank" rel="noopener">CNN</a>, the approval was granted Thursday.</p>
<h5 style="text-align: center;">RELATED: <a href="https://dev.theshaderoom.com/food-and-drug-administration-receives-first-ever-application-for-over-the-counter-birth-control-pills/" target="_blank" rel="noopener">Food And Drug Administration Receives First-Ever Application For Over-The-Counter Birth Control Pills</a></h5>
<h3 style="text-align: center;">Where The U.S.&#8217;s First Non-Prescription Birth Control Pill Will Be Available</h3>
<p>According to the outlet, Opill will be the country&#8217;s first non-prescription birth control pill as it will be available for over-the-counter purchase. An <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-nonprescription-daily-oral-contraceptive" target="_blank" rel="noopener">FDA</a> statement explains that Opill will be available at &#8220;drug stores, convenience stores and grocery stores.&#8221;</p>
<p>Additionally, the birth control pill will also be sold &#8220;online.&#8221;</p>
<p><amp-twitter data-tweetid="1679495982097260551" layout="responsive" width="600" height="480"></amp-twitter></p>
<p>Patrizia Cavazzoni, M.D., the FDA’s Center for Drug Evaluation and Research Director, also shared a statement regarding Thursday&#8217;s decision.</p>
<blockquote><p><strong>&#8220;Today’s approval marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States&#8230;&#8221;</strong></p></blockquote>
<p>Additionally, Cavazzoni explained that &#8220;daily oral contraception is safe&#8221; and &#8220;expected to be more effective&#8221; than &#8220;currently available nonprescription contraceptive methods.&#8221;</p>
<h3 style="text-align: center;">More Details About The Over-The-Counter Birth Control Pill, Opill</h3>
<p>According to <a href="https://www.cnn.com/2023/07/13/health/fda-otc-birth-control-opill/index.html" target="_blank" rel="noopener">CNN</a>, Opill uses the hormone &#8220;progestin.&#8221; The <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-nonprescription-daily-oral-contraceptive" target="_blank" rel="noopener">FDA</a> further explains that the pill should be taken daily at the same time each day.</p>
<p>Additionally, the FDA explains that common side effects of the pill may include &#8220;irregular bleeding, headaches, dizziness, nausea, increased appetite, abdominal pain, cramps or bloating.&#8221;</p>
<p>The FDA explicitly states that Opill should not be used by anyone who has or has had breast cancer. Furthermore, a doctor should be consulted for those who have battled &#8220;any other form of cancer.&#8221;</p>
<p>Lastly, the FDA explains that Opill can not be used to &#8220;prevent pregnancy after unprotected sex&#8221; or the transmission of sexual diseases, and its use should be discontinued after &#8220;pregnancy is confirmed.&#8221;</p>
<h3 style="text-align: center;">Opill&#8217;s Manufacturer Calls The FDA&#8217;s Decision A &#8220;Milestone&#8221;</h3>
<p>CNN reports that Opill&#8217;s manufacturer, Perigo, called the FDA&#8217;s decision a &#8220;milestone&#8221; for &#8220;addressing a key unmet need for contraceptive access.&#8221;</p>
<blockquote><p>&#8220;Today’s approval is a groundbreaking expansion for women’s health in the U.S., and a significant milestone towards addressing a key unmet need for contraceptive access&#8230;&#8221;</p></blockquote>
<p>Additionally, the outlet reports that Perigo pledges to make Opill “accessible and affordable to women and people of all ages.”</p>
<p>At this time, it remains unclear when Opill will begin being sold over the counter. Additionally, <a href="https://www.nbcnews.com/health/health-news/hormonal-birth-control-fda-nonprescription-contraceptive-pill-rcna93958" target="_blank" rel="noopener">NBC News</a> reports that its price point has not been disclosed.</p>
<p><amp-twitter data-tweetid="1679477124527271938" layout="responsive" width="600" height="480"></amp-twitter></p>
<p>The FDA&#8217;s decision marks a step forward for reclaiming individual reproductive agency since the overturning of Roe v. Wade. As <a href="https://dev.theshaderoom.com/supreme-court-overturns-historic-roe-v-wade-states-now-have-final-say-in-abortion-rights-legislature/" target="_blank" rel="noopener">The Shade Room</a>. previously reported, the decision gave states final authority toward abortion access.</p>
 <div class="wpra-reactions-wrap wpra-plugin-container" style="justify-content: center;;"> <div class="wpra-reactions-container" data-ver="1.3.10" data-post_id="129744" data-show_count="true" data-enable_share="onclick" data-behavior="regular" data-animation="true" data-share_url="https://dev.theshaderoom.com/fda-approves-the-countrys-first-over-the-counter-birth-control-pill/" data-secure="b649ce0b13"> <div class="wpra-call-to-action" style="color: #000000;font-size: 25px;font-weight: 600;">What Do You Think Roomies?</div> <div class="wpra-reactions wpra-static-emojis size-medium" style="border-color: #ffffff;border-width: 0px;border-radius: 50px;border-style: solid;background: #ffffff;">					<div class="emoji-8 wpra-reaction wpra-pad-fix" data-count="" data-emoji_id="8"> <div class="wpra-plus-one">+1</div>	 <div style="background-color: #ff0015" class="wpra-arrow-badge arrow-bottom-left hide-count"> <span style="border-top-color: #ff0015" class="tail"></span> <span style="color: #ffffff" class="count-num">0</span> </div>	</div><div class="emoji-10 wpra-reaction wpra-pad-fix" data-count="" data-emoji_id="10"> <div class="wpra-plus-one">+1</div>	 <div style="background-color: #ff0015" class="wpra-arrow-badge arrow-bottom-left hide-count"> <span style="border-top-color: #ff0015" class="tail"></span> <span style="color: #ffffff" class="count-num">0</span> </div>	</div><div class="emoji-4 wpra-reaction" data-count="" data-emoji_id="4"> <div class="wpra-plus-one">+1</div>	 <div style="background-color: #ff0015" class="wpra-arrow-badge arrow-bottom-left hide-count"> <span style="border-top-color: #ff0015" class="tail"></span> <span style="color: #ffffff" class="count-num">0</span> </div>	</div><div class="emoji-5 wpra-reaction" data-count="" data-emoji_id="5"> <div class="wpra-plus-one">+1</div>	 <div style="background-color: #ff0015" class="wpra-arrow-badge arrow-bottom-left hide-count"> <span style="border-top-color: #ff0015" class="tail"></span> <span style="color: #ffffff" class="count-num">0</span> </div>	</div><div class="emoji-2 wpra-reaction" data-count="" data-emoji_id="2"> <div class="wpra-plus-one">+1</div>	 <div style="background-color: #ff0015" class="wpra-arrow-badge arrow-bottom-left hide-count"> <span style="border-top-color: #ff0015" class="tail"></span> <span style="color: #ffffff" class="count-num">0</span> </div>	</div><div class="emoji-7 wpra-reaction" data-count="" data-emoji_id="7"> <div class="wpra-plus-one">+1</div>	 <div style="background-color: #ff0015" class="wpra-arrow-badge arrow-bottom-left hide-count"> <span style="border-top-color: #ff0015" class="tail"></span> <span style="color: #ffffff" class="count-num">0</span> </div>	</div><div class="emoji-12 wpra-reaction" data-count="" data-emoji_id="12"> <div class="wpra-plus-one">+1</div>	 <div style="background-color: #ff0015" class="wpra-arrow-badge arrow-bottom-left hide-count"> <span style="border-top-color: #ff0015" class="tail"></span> <span style="color: #ffffff" class="count-num">0</span> </div>	</div> </div> <div class="wpra-share-wrap wpra-share-buttons-bordered" style="">				 </div> <!-- end of share buttons -->			 </div> <!-- end of reactions container --> </div> <!-- end of reactions wrap -->		
